Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACCESS HCM: Real World Evidence for Artificial-Intelligence-assisted Screening and Access to Care for HCM - A Multi-Site Registry

NCT07103057 is registered in ClinicalTrials.gov with Viz.ai, Inc. as lead sponsor.

NCT NCT07103057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07103057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACCESS HCM: Real World Evidence for Artificial-Intelligence-assisted Screening and Access to Care for HCM - A Multi-Site Registry
Lead sponsor
Viz.ai, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 13, 2025
Completion date
September 17, 2026
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy